SHINGLES VACCINE RESEARCH STUDY PERSONS AGE 50 AND OLDER

Primary Objective

The University of Colorado Anschutz is conducting a research study to learn more about how shingles vaccines prevent shingles. Researchers want to learn more about how shingles vaccines prevent shingles and are looking for people who have never had shingles and received a Shingles Vaccine (either Zostavax or Shingrix) 5 or more years ago.

Is this Study for You?

Let's Get Started!

Description

We are recruiting for 2 groups; you may be eligible to participate if you are • Age 50 or older • In general good health, and • Have never had shingles, and * Received a shingles vaccine = 5 years ago and can provide documentation - OR - * Never received a shingles vaccine

Main Procedures Involved: Procedures include blood draws, administration of a challenge dose of shingles vaccine, and may include a skin biopsy. The FDA approved Shingrix vaccine will be offered at study conclusion to participants who’ve never received it before.

Duration of Participation: Study Duration for group who has received a Shingles Vaccine = 5 years ago is 10 days. Study Duration for group who has never received a Shingles Vaccine is 5 months.

Details
Age

50 to years

Compensation

Compensation Provided

Locations

CU Anschutz non-hospital research facilities

Study ID

Protocol Number: 18-0580

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers